Thiolated chitosan nanoparticles: transfection study in the Caco-2 differentiated cell culture
Authors:
- Ronny MartienRMRonny Martien
- Brigitta LoretzBLBrigitta Loretz
- Adolf Michael SandbichlerASAdolf Michael Sandbichler
- Andreas Bernkop SchnürchASAndreas Bernkop Schnürch
- 4 January 2008
- journal article
- Published by IOP Publishing in Nanotechnology
- Vol. 19 (4) , 045101
Abstract
The aim of this study was to monitor the expression of secreted protein in differentiated Caco-2 cells after transfection with nanoparticles, in order to improve gene delivery. Based on unmodified chitosan and thiolated chitosan conjugates, nanoparticles with the gene reporter pSEAP (recombinant Secreted Alkaline Phosphatase) were generated at pH 4.0. Transfection studies of thiolated chitosan in Caco-2 cells during the exponential growth phase and differentiation growth phase of the cells led to a 5.0-fold and 2.0-fold increase in protein expression when compared to unmodified chitosan nanoparticles. The mean particle size for both unmodified chitosan and cross-linked thiolated chitosan nanoparticles is 212.2 ± 86 and 113.6 ± 40 nm, respectively. The zeta potential of nanoparticles was determined to be 7.9 ± 0.38 mV for unmodified chitosan nanoparticles and 4.3 ± 0.74 mV for cross-linked thiolated chitosan nanoparticles. Red blood cell lysis evaluation was used to evaluate the membrane damaging properties of unmodified and thiolated chitosan nanoparticles and led to 4.61 ± 0.36% and 2.29 ± 0.25% lysis, respectively. Additionally, cross-linked thiolated chitosan nanoparticles were found to exhibit higher stability toward degradation in gastric juices. Furthermore the reversible effect of thiolated chitosan on barrier properties was monitored by measuring the transepithelial electrical resistance (TEER) and is supported by immunohistochemical staining for the tight junction protein claudin. According to these results cross-linked thiolated chitosan nanoparticles have the potential to be used as a non-viral vector system for gene therapy.Keywords
This publication has 29 references indexed in Scilit:
- Chitosan–thioglycolic acid conjugate: An alternative carrier for oral nonviral gene delivery?Journal of Biomedical Materials Research Part A, 2007
- Oral gene delivery: Design of polymeric carrier systems shielding toward intestinal enzymatic attackBiopolymers, 2006
- Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene DeliveryPharmacological Reviews, 2006
- Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugateInternational Journal of Pharmaceutics, 2004
- Thiolated chitosansEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticlesBiomaterials, 2002
- Synthesis, Development andIn VitroEvaluation of Drug Delivery Systems with Protective Effect against Degradation by PepsinJournal of Drug Targeting, 1999
- Gene Transfer to the Intestinal Tract: A New Approach Using Selective Injection of the Superior Mesenteric ArteryHuman Gene Therapy, 1997
- Efficient Gene Delivery with Neutral Complexes of Lipospermine and Thiol-Reactive PhospholipidsBiochemical and Biophysical Research Communications, 1995
- Improving Access to Intestinal Stem Cells as a Step Toward Intestinal Gene TransferHuman Gene Therapy, 1994